Viral hepatitis B and C are major health challenges, affecting 325 million people globally.  They are root causes of liver cancer, leading to 1.34 million deaths every year. 

Hepatitis B and C are chronic infections that may not show symptoms for a long period, sometimes years or decades. At least 60% of liver cancer cases are due to late testing and treatment of viral hepatitis B and C. Low coverage of testing and treatment is the most important gap to be addressed in order to achieve the global elimination goals by 2030.